Skip to content
B
BiotechEdge

Dynavax Technologies + Sanofi

closed

$DVAX acquired by Sanofi for $1.8B

Deal Summary

Deal Value
$1.8B
Price/Share
$15.5
Announced
Dec 10, 2025
Closed
Feb 10, 2026

Fund Positioning

3 of 20 tracked specialist biotech funds held $DVAX — based on SEC 13F filings.

FundSharesValueEntryAt Announcement
Deep Track Capital15.7M$241.9MDec 2025No
Deerfield Management5.2M$67.3MMar 2025Yes
Tang Capital Management556K$8.6MDec 2025No
← All biotech acquisitions